Literature DB >> 8452365

Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro.

U M Morgan1, J A Reynoldson, R C Thompson.   

Abstract

Previous studies in our laboratory have shown that albendazole is effective against Giardia spp. in vitro and in vivo, prompting an investigation of the effects of several related benzimidazoles (BZs) on the viability of this protozoan parasite. A range of BZs was tested, and their effects were compared with those of a number of microtubule inhibitors. The effects produced by the two types of drugs were markedly similar, namely, trophozoite detachment and distortion of morphology and general structure, indicating a potential antimicrotubule mode of action for BZs. Mebendazole, albendazole, and fenbendazole proved to be among the most effective BZs tested, exhibiting apparent irreversibility. Nocodazole, oxfendazole, and albendazole sulfoxide, among others, produced transient inhibitions only. Further studies are required to evaluate all available BZs and other antigiardial agents to ensure the development of the most effective and safest antigiardial agent possible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452365      PMCID: PMC187662          DOI: 10.1128/AAC.37.2.328

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Benzimidazoles in a wormy world.

Authors:  R J Horton
Journal:  Parasitol Today       Date:  1990-04

2.  Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin.

Authors:  J Hoebeke; G Van Nijen; M De Brabander
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

Review 3.  The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles.

Authors:  E Lacey
Journal:  Int J Parasitol       Date:  1988-11       Impact factor: 3.981

4.  Failure of mebendazole treatment in Giardia lamblia infection.

Authors:  J Gascon; A Moreno; M E Valls; J M Miró; M Corachán
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Sep-Oct       Impact factor: 2.184

5.  A possible biochemical mode of action for benzimidazole anthelmintics.

Authors:  R O McCracken; W H Stillwell
Journal:  Int J Parasitol       Date:  1991-02       Impact factor: 3.981

6.  Age-related rate of seropositivity of antibody to Giardia lamblia in four diverse populations.

Authors:  P G Miotti; R H Gilman; M Santosham; R W Ryder; R H Yolken
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Mode of action of benzimidazoles.

Authors:  E Lacey
Journal:  Parasitol Today       Date:  1990-04

8.  The giardins of Giardia lamblia: genes and proteins with promise.

Authors:  D A Peattie
Journal:  Parasitol Today       Date:  1990-02

9.  The molecular nature of benzimidazole resistance in helminths.

Authors:  M H Roos
Journal:  Parasitol Today       Date:  1990-04

10.  Comparative studies on the axenic in vitro cultivation of Giardia of human and canine origin: evidence for intraspecific variation.

Authors:  B P Meloni; R C Thompson
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

View more
  21 in total

Review 1.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Disc-associated proteins mediate the unusual hyperstability of the ventral disc in Giardia lamblia.

Authors:  Christopher Nosala; Kari D Hagen; Nicholas Hilton; Tiffany M Chase; Kelci Jones; Rita Loudermilk; Kristofer Nguyen; Scott C Dawson
Journal:  J Cell Sci       Date:  2020-08-27       Impact factor: 5.285

3.  Survey of intestinal parasites in stray dogs in the Madrid area and comparison of the efficacy of three anthelmintics in naturally infected dogs.

Authors:  Guadalupe Miró; Marta Mateo; Ana Montoya; Enrique Vela; Rosa Calonge
Journal:  Parasitol Res       Date:  2006-08-17       Impact factor: 2.289

Review 4.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 5.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children.

Authors:  Roberto Canete; Angel A Escobedo; Maria E Gonzalez; Pedro Almirall
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

7.  Small molecule screen for compounds that affect vascular development in the zebrafish retina.

Authors:  Satish S Kitambi; Kyle J McCulloch; Randall T Peterson; Jarema J Malicki
Journal:  Mech Dev       Date:  2009 May-Jun       Impact factor: 1.882

8.  Giardia lamblia: a report of drug effects under cell differentiation.

Authors:  Moema A Hausen; Richard Pereira de Oliveira; Ana Paula Rocha Gadelha; Loraine Campanati; Jorge José de Carvalho; Laís de Carvalho; Helene Santos Barbosa
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

9.  A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.

Authors:  Noa Tejman-Yarden; Yukiko Miyamoto; David Leitsch; Jennifer Santini; Anjan Debnath; Jiri Gut; James H McKerrow; Sharon L Reed; Lars Eckmann
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

10.  Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence.

Authors:  S K Katiyar; V R Gordon; G L McLaughlin; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.